In this issue:
- Treating migrants with latent TB: primary vs. secondary care
- TB RNA signatures for discriminating persistent culture positivity after anti-TB treatment
- High-dose isoniazid: bactericidal activity against isoniazid-resistant katG-mutated TB
- Hidden isoniazid-resistant TB epidemic in South Africa
- TB prevention by age group and infection status
- TB counselling and cash for improving TB treatment in South Africa
- Effect of (pre)diabetes on pulmonary TB treatment outcomes
- Predicting mortality risk in pulmonary TB
- TB in adult migrants in Europe
- Novel four-drug combination for drug-sensitive and -resistant pulmonary TB
- Intermittent multidrug intravenous therapy for refractory M. abscessus pulmonary disease
- Human mesenchymal stromal cells inhibit M. avium replication
Please login below to download this issue (PDF)